Levopalm Syrup Mango contains Levocetirizine dihydrochloride 5 mg per 5 ml, an advanced non-sedating antihistamine indicated for the relief of allergic conditions. Levocetirizine, a selective H1 receptor antagonist, effectively inhibits the action of histamine, thereby reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis, as well as urticaria and other dermatological allergic manifestations. The syrup formulation, flavored with mango, facilitates ease of administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Levopalm Syrup Mango demonstrates rapid onset of action and sustained efficacy over 24 hours, allowing once-daily dosing. It is well-tolerated with a low incidence of sedation and minimal anticholinergic side effects. The syrup should be used as directed by a healthcare professional, with dosage adjustments considered in patients with renal impairment. Contraindications include hypersensitivity to Levocetirizine or any excipients within the formulation. Caution is advised in patients with severe renal dysfunction. Levopalm Syrup Mango offers an effective and convenient therapeutic option for managing allergic symptoms, improving patient compliance and quality of life.